SHAREHOLDER ALERT: WeissLaw LLP Reminds ANCN, PRVL, WORK, and GNBF Shareholders About Its Ongoing Investigations

NEW YORK, Jan. 6, 2021 /PRNewswire/ --

If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:

Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16^th Floor
New York, NY  10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

Anchiano Therapeutics Ltd. ANCN

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Anchiano Therapeutics Ltd. ANCN in connection with the company's proposed merger with Chemomab Ltd. ("Chemomab"). ANCN will combine with Chemomab via a reverse-merger to create a publicly traded company. Upon closing of the proposed transaction, ANCN shareholders will only own approximately 10% of the combined company, prior to additional PIPE financing. If you own ANCN shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/ancn/   

Prevail Therapeutics Inc. PRVL

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Prevail Therapeutics Inc. PRVL in connection with the proposed acquisition of the company by Eli Lilly and Company. Under the terms of the agreement, PRVL shareholders will only receive $22.50 per share in cash and a contingent value right of up to $4.00 for each PRVL share that they hold. If you own PRVL shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/prvl/

Slack Technologies, Inc. WORK

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Slack Technologies, Inc. WORK in connection with the proposed acquisition of the company by salesforce.com, inc. ("Salesforce"). Under the terms of the agreement, WORK shareholders will receive $26.79 and 0.0776 shares of Salesforce common stock for each share of WORK that they own, representing implied per-share consideration of $44.05 based upon Salesforce's January 5, 2021 closing price of $42.01. If you own WORK shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/work/ 

GNB Financial Services, Inc. GNBF

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of GNB Financial Services, Inc. GNBF in connection with the proposed merger of the Company with LINKBANCORP, Inc. ("LINKBANCORP"). Under the terms of the agreement, GNBF shareholders may elect to receive either $87.68 in cash or 7.3064 shares of LINKBANCORP stock for each GNBF share they own. If you own GNBF shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/gnbf/

SOURCE WeissLaw LLP